Back to results
Not yet recruitingPhase 2

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

NCT06820281

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Garvan Institute of Medical Research

Sydney, New South Wales, Australia

Contact

Jennifer R Snaith, MD PHD

+61 2 9295 8600j.snaith@victorchang.edu.au
View on ClinicalTrials.gov
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes — TrialFind